title: [Respective interest of two techniques of electrophysiological study in patient without heart disease].
abstract: Electrophysiologic study (EPS) frequently is required to assess the prognosis of asymptomatic Wolff-Parkinson-White syndrome (WPW) or to prove the nature of no documented tachycardia. EPS usually is performed by intracardiac route and hospitalization is required. Similar data are given by an EPS performed by oesophageal route during a consultation. The purpose of the study was to evaluate the cost of both techniques in France. Transesophageal EPS was performed during a consultation in 100 patients with asymptomatic WPW syndrome and 100 patients with no heart disease, complaining of no documented tachycardias with abrupt beginning and end, suggesting a paroxysmal junctional re-entrant tachycardia (PJRT). The cost of transesophageal study including isoproterenol infusion is 127.75 euros. The cost of intracardiac EPS is at least 1460 euros, cost of hospitalization during only one day.
  
  
  RESULTS
  In patients with WPW syndrome, 15 had a potentially malignant form with the induction of a tachycardia conducted through the accessory pathway at a high rate (> 240/min in control state, > 300/min with isoproterenol); radiofrequency catheter ablation was indicated in a second time. In the group with no documented tachycardia, PJRT was induced in 30 patients and indication of ablation was discussed. In other 155 patients with either a benign form of WPW syndrome or with a tachycardia unrelated to a PJRT, hospitalization was not required; in these patients, intracardiac study performed during one day of hospitalization would have costed 226,300 Euros. The cost for the esophageal EPS and a similar diagnosis was 19,801 Euros, with a save money of 206,499 Euros. In 45 patients in whom hospitalization was indicated in a second time to perform catheter ablation of the arrhythmia, the cost related to esophageal EPS was 5749 Euros. In the total group, considering the final diagnosis and the need of hospitalization in 45 patients, the save money related to the use of esophageal EPS was 206,499 E-5749 E = 200,750 euros.
  
  
  CONCLUSIONS
  We should take into account the cost studies, when various techniques could be used for a similar diagnosis. There are important differences in the cost of diagnostic methods and it is easy to decrease this cost.
authors.affiliation: Service de cardiologie, CHU de Brabois, rue du Morvan, 54500 Vandoeuvre-Les-Nancy, France. b.brembilla-perrot@chu-nancy.fr
authors.forename: B
authors.initials: B
authors.lastname: Brembilla-Perrot
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000553:Ambulatory Care / Q000191:economics; D002316:Cardiotonic Agents / Q000191:economics; D017115:Catheter Ablation; D002648:Child; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D022062:Electrophysiologic Techniques, Cardiac / Q000191:economics / Q000379:methods*; D005602:France; D006760:Hospitalization / Q000191:economics; D006801:Humans; D007545:Isoproterenol / Q000191:economics; D008875:Middle Aged; D013614:Tachycardia, Paroxysmal / Q000175:diagnosis; D013615:Tachycardia, Sinoatrial Nodal Reentry / Q000175:diagnosis; D014927:Wolff-Parkinson-White Syndrome / Q000175:diagnosis
chemical_list: D002316:Cardiotonic Agents; D007545:Isoproterenol